The effect of self-monitoring urate concentrations on adherence to allopurinol in people with gout

Not Applicable

Completed

• Conditions: Gout; Musculoskeletal - Other muscular and skeletal disorders

• Registration Number: ACTRN12621001730897
• Lead Sponsor: SW Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-20
• Study Completion: 2022-05-23
• Last Update Posted: 5 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

At least 18 years old.
Proficient in English.
Lives in the jurisdiction of Australia
Has self-reported gout
Is on allopurinol therapy

Exclusion Criteria

Uses a weekly medication planner e.g. a Webster pack
Has a caregiver involved in medication taking.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adherence to allopurinol as measured by electronic monitoring using MEMS.[ Medication adherence is measured daily for 12-months post intervention commencement.]